Company announcements, research highlights and demonstrations.
3DR Labs and Deep Reasoning AI Inc. announce 510(k) clearance from the U.S. Food and Drug Administration for NeuroDR. NeuroDR is a first-of-its-kind, fully automated, AI-driven Software as a Medical Device (SaMD) designed for high-precision neurovascular 3D segmentation, anatomical modeling, and vessel centerlining.
FDA 510(k) clearance number K262134
The collaboration combines Deep Reasoning’s AI technology with 3DR Labs’ image post-processing expertise to advance automated CTA segmentation and vessel centerlining.
Deep Reasoning AI received an NIH grant for $350,000 to develop 3D anatomical modeling and virtual surgical planning for craniomaxillofacial reconstruction, with Dr. Jonathan Morris of Mayo Clinic as principal investigator and Dr. Di Chen of Deep Reasoning AI as co-principal investigator.
NIH project number 1R41DE034646-01
Research by members of our team on deep reasoning networks for materials discovery was featured in Nature Machine Intelligence.